Fundraising Fox
Engage Venture Partners
Venture capitalActively deploying6 people tracked
Find your way into Engage Venture Partners
Sign up to see every warm intro you have to Engage Venture Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Engage Venture Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fund manager profile
Engage Venture Partners is a venture fund manager. SEC filings show 10 venture funds on record, most recently SPV014 a Series of Engage Venture Partners Investments LLC ($782.5K offering) filed November 2025.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 6 people
from public directories
What they invest in
from 3 of 3 portfolio companiesHealthtech ×3Medical Devices ×3Biotech ×1FemTech ×1Hardware ×1
HQs:United States×3
Investments · 3 tracked
founders shown can be your intro pathBy year:2025 · 22023 · 13 dated
Melodi Health is a medical device company focused on breast reconstruction and breast procedures, developing implantable combination devices with expertise in infection control and plastic reconstructive surgery.
FemTechHardwareHealthtechMedical DevicesMinneapolis, US
Sarah Worrell(Co-founder & Chief Executive Officer)inMichele Hilmer(Chief Strategy Officer)Hunter Moyer, MD(Chief Medical Officer)Kaitlyn Roth(VP Operations)inMatthew Hemsley(Director)Arikha Moses(Director)
Co-investorsHM Venture PartnersSoutheast Minnesota Capital Fund
Agitated Solutions, Inc.
BiotechHealthtechMedical DevicesSaint Paul, US
Morgan E. Evans(Executive Officer, Director)Morgan Clyburn(Executive Officer, Director)Robert A. Kukuljan(Executive Officer)
BoardKathleen Tune(Director)Micah Eimer(Director)Mark Pacyna(Director)
Co-investorsGROOVE CAPITAL
Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation.
HealthtechMedical DevicesPlymouth, US
Ramji Iyer(Executive Officer, Director)in
BoardJenny H. Barba(Director)Todd Mortier(Director)Colin Morrison(Director)
Co-investorsAphelion CapitalFeatures Capital Holdingsgener8torShangBay Capital LLCUnorthodox VenturesAphelion Cardeation
